Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Lafay-Cousin L, Bouffet E (2011) In response to “Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low grade glioma”. Support Care Cancer. doi: 10.​1007/​s00520-011-1309-3
2.
Genc DB, Canpolat C, Berrak SG (2012) Clinical features and management of carboplatin-related hypersensitivity reactions in pediatric low-grade glioma. Support Care Cancer 20(2):385–393PubMedCrossRef
3.
Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM (2007) Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49(6):808–811PubMedCrossRef
4.
Cappellano Am, Cavalheiro S, Bergamo M, Carmona P, Soares MFF, Tostes VS, Seixas MT, da Silva NS (2010) Vinorelbine in progressive unresectable low-grade glioma: experience of a single institution. Neuro-Oncology 12(6):ii20
5.
Ater J, Holmes E, Zhou T, Mazewski C, Roberts W, Vezina G, Booth T, Freyer D, Kadota R, Jakacki R, Packer R, Prados M, Pollack I (2008) Results of the COG protocol 9952: a randomized phase 3 study of 2 chemotherapy regimens for incompletely resected low grade glioma in young children. Neuro-Oncology 10:452
Metadata
Title
Response letter to the editor
Authors
Dildar Bahar Genc
Cengiz Canpolat
Su Gulsun Berrak
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1421-z

Other articles of this Issue 6/2012

Supportive Care in Cancer 6/2012 Go to the issue

Original Article

Role recognition and changes to self-identity in family caregivers of people with advanced cancer: a qualitative study

Original Article

Unmet supportive care needs in colorectal cancer: differences by age

Original Article

Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials

Original Article

Utilization of hypnotic medication in the context of cancer: predictors and frequency of use

Original Article

Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy

Original Article

Gastrointestinal symptoms, electrogastrography, inflammatory markers, and PG-SGA in patients with advanced cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits